Open Access

SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis

  • Authors:
    • Ao Ding
    • Ying‑Ying Bian
    • Zhi‑Hong Zhang
  • View Affiliations

  • Published online on: January 27, 2020     https://doi.org/10.3892/mmr.2020.10965
  • Pages: 1581-1589
  • Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The relationship between osteoblasts and angiogenesis is vital for bone regeneration, especially mandibular and maxillary bones. Transforming growth factor β1 (TGF‑β1) and vascular endothelial growth factor (VEGF) are closely related to angiogenesis; however, the regulatory mechanism between them remains unknown. The present study aimed to reveal this mechanism to provide novel insight for development of potential therapeutic opportunities. Western blotting and reverse transcription‑quantitative PCR was used to assess the protein and mRNA expression levels in MC3T3‑E1 preosteoblast cells and HUVECs, ELISAs were used to detect the expression levels of secreted VEGF, MTT assays were used to assess the viability of the cells, migratory ability was assessed using Transwell assays, angiogenesis assays were used to analyze the formation of blood vessels, and TGF‑β1 regulation was confirmed using a dual‑luciferase reporter assay. The overexpression of specificity protein 1 (SP1) or TGF‑β1 increased VEGF expression levels and secretion, and promoted angiogenesis of co‑cultured HUVECs. SP1 also promoted SMAD2 phosphorylation. These effects of SP1 were all reversed by the TGF‑β1 inhibitor. The VEGF inhibitor bevacizumab also reduced the SP1/TGF‑β1/SMAD2 pathway‑induced angiogenesis of preosteoblasts. In conclusion, it was demonstrated that SP1 promoted TGF‑β1 expression, activated the SMAD2 pathway and induced VEGF secretion, which may enhance angiogenic processes in preosteoblasts.
View Figures
View References

Related Articles

Journal Cover

March 2020
Volume 21 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Ding, A., Bian, Y., & Zhang, Z. (2020). SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis. Molecular Medicine Reports, 21, 1581-1589. https://doi.org/10.3892/mmr.2020.10965
MLA
Ding, A., Bian, Y., Zhang, Z."SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis". Molecular Medicine Reports 21.3 (2020): 1581-1589.
Chicago
Ding, A., Bian, Y., Zhang, Z."SP1/TGF‑β1/SMAD2 pathway is involved in angiogenesis during osteogenesis". Molecular Medicine Reports 21, no. 3 (2020): 1581-1589. https://doi.org/10.3892/mmr.2020.10965